Curia’s global API aseptic processing manufacturing network has served a broad portfolio of customers worldwide for more than 20 years. This investment positions the company to support increasingly ...

In the current industry landscape, API quality can make or break a drug product. LGM Pharma stands out by treating supplier relationships as strategic partnerships rather than transactions. In this ...

Syngene had successfully demonstrated the small-scale synthesis of a novel vascular calcification inhibitor API from lab-scale to tox-batch manufacturing. This was following the request of a pharma ...

Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments.

The CDMO’s latest investment will boost capacity at its Charles City, IA facility by 40%, underscoring Cambrex’s focus on ...

Sudarshan Pharma Industries Ltd (SPIL), a key Indian player in pharmaceutical manufacturing and distribution, has been officially recognised as a One Star Export House by the Directorate General of ...